| Literature DB >> 34941760 |
Juana Sánchez-Alarcón1,2, Mirta Milić3, Lilia Patricia Bustamante-Montes4, Keila Isaac-Olivé5, Rafael Valencia-Quintana2, Ninfa Ramírez-Durán5.
Abstract
Beside partial coverage in three reviews so far (1994, 2009, 2019), there is no review on genotoxic studies dealing with mercury (Hg) and human exposure using the most usual genotoxic assays: sister chromatid exchanges (SCE), chromosomal aberrations (CA), cytochalasin B blocked micronucleus assay (CBMN), and single-cell gel electrophoresis (SCGE or alkaline comet assay). Fifty years from the first Hg genotoxicity study and with the Minamata Convention in force, the genotoxic potential of Hg and its derivatives is still controversial. Considering these antecedents, we present this first systematic literature overview of genotoxic studies dealing with Hg and human exposure that used the standard genotoxic assays. To date, there is not sufficient evidence for Hg human carcinogen classification, so the new data collections can be of great help. A review was made of the studies available (those published before the end of October 2021 on PubMed or Web of Science in English or Spanish language) in the scientific literature dealing with genotoxic assays and human sample exposure ex vivo, in vivo, and in vitro. Results from a total of 66 articles selected are presented. Organic (o)Hg compounds were more toxic than inorganic and/or elemental ones, without ruling out that all represent a risk. The most studied inorganic (i)Hg compounds in populations exposed accidentally, occupationally, or iatrogenically, and/or in human cells, were Hg chloride and Hg nitrate and of the organic compounds, were methylmercury, thimerosal, methylmercury chloride, phenylmercuric acetate, and methylmercury hydroxide.Entities:
Keywords: chromosomal aberrations; comet assay; micronucleus assay; sister chromatid exchange
Year: 2021 PMID: 34941760 PMCID: PMC8704886 DOI: 10.3390/toxics9120326
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Studies on in vitro genotoxic effects by inorganic Hg compounds.
| Compound | Cell Type | Assay | Concentrations | Results | References |
|---|---|---|---|---|---|
| mercury chloride | L | CA | <3.0 × 10−8 M | No significant differences ( | Paton and Allison 1972 [ |
| WB | SCE | 8 × 10−8 M–2.5 × 10−4 M | Dose-dependent increase from 4 × 10−7 M, 10.57 ± 0.55 SCE/cell ( | Morimoto et al. 1982 [ | |
| Ly | CA | 1–150 µM | Significant increase from 50 µM, with 5.00% of chromatid- or chromosome-type aberrations ( | Verschaeve et al. 1985 [ | |
| WB | MN | 10−3–10−1 M | A linear increase in MN frequency. | Bérces et al. 1993 [ | |
| Ly | CA | 2–50 µM | Dose-dependent increase from 5 × 10−6 M with 7.3 ± 0.9 CA ( | Ogura et al. 1996 [ | |
| MN | Significant increase at 20 × 10−6 and 50 × 10−6 M with 43 and 65 cells with MN cells respectively ( | ||||
| 8-OHdG | 5–20 µM | Significant increase of 8-OHdG levels at 10 × 10−6 M (1.047 ± 0.202) and 20 × 10−6 M (2.091 ± 0.539) ( | |||
| TK6 | CA | 10–2000 ppb | No significant differences ( | Bahia et al. 1999 [ | |
| HPRT | 0.1–1000 ppb | ||||
| WRL-68 | SCGE | 0.5 µM, 5 µM | Significant differences ( | Bucio et al. 1999 [ | |
| U-937 | SCGE | 1–50 µM | With 5 µM mean TL at 24 h was 5.5 ± 0.06 mm; at 48 h, 7.2 ± 0.06 mm; and at 72 h, 8.9 ± 0.04 mm. | Ben-Ozer et al. 2000 [ | |
| L | SCE | 1.052, 5.262 and 10.524 µM | Significant increase for lowest ( | Rao et al. 2001 [ | |
| L | CA | Significant increase at higher concentrations for C-anaphases ( | |||
| Ly | CA | 0.1–1000 μg/L | Significant gaps and breaks increase ( | Silva-Pereira et al. 2005 [ | |
| Ly | CBMN | 10, 50, 100, and 200 mM | 24 h exposure- no significant difference. 48 h- no dose-related-MN frequency increase | Rozgaj et al. 2006 [ | |
| WB | SCGE | 10, 50, 100 and 200 mM | 24 h exposure- TL increase at 50, 100 mM ( | Milić et al. 2006 [ | |
| Ly | SCGE | 1–50 µM | A significant ( | Schmid et al. 2007 [ | |
| PSG | A significant | ||||
| TK6 | SCGE | 0.01–2 µM | A significant dose-dependent increment in OTM from 0.1 µM ( | Guillamet et al. 2008 [ | |
| Hg nitrate | Ly | SCE | 1–30 µM | No significant differences ( | Lee et al. 1997 [ |
| EM | 30 µM | Significant increase ( |
L—human leukocytes; Ly—human lymphocytes; WB—whole blood; WRL-68—human liver cell line; TK6—human lymphoblastoid cell line; U-937 human macrophage cell line; -PSG—parotid salivary gland cells; CBMN—cytokinesis B blocked micronucleus assay; CA—chromosomal aberrations; SCE—sisters chromatid exchange; C—anaphase; MN- micronuclei; 8-OHdG—8-Hydroxy-2’-deoxyguanosine; EM—endoreduplicated mitosis; SCGE—single cell gel electrophoresis or alkaline comet assay with parameters: TL—tail length (µm), TM—tail moment; TI—tail intensity (%); OTM—Olive Tail Moment; Mf—mutant frequency; HPRT—hypoxanthine phosphoribosyltransferase.
Studies on in-vitro genotoxic effects by organic Hg compounds.
| Compound | Cell type | Assay | Concentrations | Results | References |
|---|---|---|---|---|---|
| C2H5HgCl, C6H5HgCl | HeLa | CA | 1.0–1.8 µg/mL | Significant increase | Umeda et al. 1969 [ |
| methyl mercury | Ly | CA | 0.05–0.5 ppm | 18.7% chromosome breakage, 2.6% chromosome reunions and rearrangements | Kato and Nakamura 1976 [ |
| PB | SCE | 8 × 10−8–2.5 × 10−4 M | Significant increase from 8 × 10−8 (10.49 ± 0.55 SCE/cell) up to 2 × 10−6 M (12.69 ± 0.60 SCE/cell) vs. control (8.86 ± 0.50) ( | Morimoto et al. 1982 [ | |
| Ly | CA | 5–30 µM | Significant increase of chromatid type aberrations from 5 µM (12.87%) up to 30 µM (24%) vs. control (1.00%) and chromosome type aberrations from 5 µM (3.96%) up to 30 µM (16.00%) vs. control (0.00%) ( | Verschaeve et al. 1985 [ | |
| Ly | CA | 0.12–25 µM | Significant increase from 0.6 × 10−6 M up to 25 × 10−6 M in structural CA (10.00 ± 1.63–23.00 ± 3.46) vs. control (4.50 ± 2.51) and numerical CA (2.50 ± 3.00–10.50 ± 3.41) vs. control (0.00) ( | Betti et al. 1992 [ | |
| Ly | CA | 3–25 µM | Significant increase from 5 µM (6.00 ± 2.82) up to 25 µM (12.00 ± 8.48) ( | Betti et al. 1993 [ | |
| SCE | Significant increase at 5 µM (7.44 ± 2.44% SCE) and 15 µM (8.04 ± 2.90% SCE) vs. control (5.92 ± 1.84) µM ( | ||||
| PB/Ly | CA | 1–10 µM | Significant increase at 5 µM (9.3 ± 1.7) and 10 µM (22.3 ± 5.9) vs. control (3.0 ± 0.0)( | Ogura et al. 1996 [ | |
| MN | Significant increase of MN in 3000 cells at 5 µM (43) and 10 µM (65) ( | ||||
| PB/Ly | 8-OHdG | 1–10 µM | The level of 8-OHdG was also significantly ( | Ogura et al. 1996 [ | |
| Ly | SCE | 0.3–20 µM | Significant increase at 20 µM (11.4 ± 0.5 SCE/cell) vs. control 7.0 ± 0.4) ( | Lee et al. 1997 [ | |
| EM | 20 µM | Significant increase ( | |||
| Ly | CA | 0.1–1000 μg/L | Significant increment of CA from 13.5% at 0.1 μg/L to 12.2% at 1000 μg/L not dose related and polyploidy from 13.0 ± 1.3546 at 0.1 μg/L to 64.3 ± 1.8961 dose related ( | Silva-Pereira et al. 2005 [ | |
| U373 | CBMN | 0.1 and 1 μM | Significant increase between 11–12% in the frequency of micronucleated cells ( | Crespo-López et al. 2007 [ | |
| B103 | Non-significant increase in frequency of MN cells between 6–8% in the frequency of micronucleated cells ( | ||||
| TK6 | SCGA | 0.01–3 μM | Significant increment inn OTM ( | Guillamet et al. 2008 [ | |
| PB | MN, CA | 1–500 μg/L or 0.004–2 μM | Loss of cells proliferative capacity, very low frequency of MN (0.3 at 1, 10 and 50 μg/L), no correlation with Hg concentration, no CA | Crespo-López et al. 2011 [ | |
| C6 | SCGE, CBMN | 3 μM | Significant increase of TI, MN and NA ( | Crespo-López et al. 2016 [ | |
| SH-SY5Y | SCGE | 3–30 mg/L CH3HgCl | Significant increase of fragmentation index from 7 ± 2.64% at 3 mg/L up to 98.6 ± 0.57% at 30 mg/L and TL from 1.6 ± 0.25 µm at 3 mg/L up to 32.8 ± 1.53 µm at 30 mg/L | Patnaik and Padhy 2018 [ | |
| 3–42 mg/L CH3HgOH | Significant increase of fragmentation index from 3 ± 1.73% at 3 mg/L up 98 ± 0.57% at 30 mg/L and TL from 2.2 ± 0.95 µm at 3 mg/L up to 20.4 ± 0.77 µm at 30 mg/L | ||||
| [(CH3)2Hg] | Ly | CA | 0.34–434 µM | Significant increase in structural CA at 43.4 × 10−6 M (9.00 ± 2.58), 217 × 10−6 M (9.50 ± 3.00 and 434 × 10−6 M (12.00 ± 2.82) vs. control (4.50 ± 2.51) and numerical CA from 1.73 (2.50 ± 1.00) up to 434 (5 ± 2) vs. control (0.00) ( | Betti et al. 1992 [ |
| PMA | Ly | SCE | 1–30 µM | Significant SCE increase from 10 µM (9.5 ± 0.4 SCE/cell) up to 30 (14.9 ± 0.6) µM vs. control (7.0 ± 0.4) ( | Lee et al. 1997 [ |
| EM | Significant increase from 3 µM (3.1 ± 0.7) up to 30 (15.2 ± 0.9) µM vs. control (0.4 ± 0.3) ( | ||||
| thiomersal | Ly | CBMN | 0.05 and 0.6 µg/mL | Significant induction ( | Westphal et al. 2003 [ |
| Ly | SCE, ±S9 metabolic activation | 0.2–0.6 µg/mL | Significant SCE induction ( | Eke and Celik 2008 [ |
HeLa—human cervix epithelioid carcinoma cell line; MN- micronuclei; CBMN—cytokinesis blocked micronucleus assay; SH-SY5Y—human neuroblastoma cell line; C6—glioma cell line; U373—glioblastoma; B103—neuroblastoma; TK6—human lymphoblastoid cell line; PB—peripheral blood; Ly—human lymphocytes; CA—chromosomal aberrations; SCE—sister chromatid exchange; 8-OHdG—8-Hydroxy-2’-deoxyguanosine; EM- endoreduplicated mitosis; E—endoreduplication; SCGE—single cell gel electrophoresis or comet assay; PMA—phenylmercury acetate; C2H5HgCl—ethylmercury chloride; C6H5HgCl—Phenylmercury chloride or PMA; [(CH3)2Hg]—Dimethylmercury; TL-tail length; TI-tail intensity; TM-tail moment; OTM—Olive Tail Moment; MI- mitotic index; PRI—proliferation index.
Genotoxic effects in human populations exposed to Hg compounds.
| Compound | Cell Type/Assay | Exposure Biomarker | Origin of Hg | E/C ( | Results | Country | Reference |
|---|---|---|---|---|---|---|---|
| methylmercury | Ly/CA | Hg levels in RBC | dietary contaminantes fish | 9/4 | CA-Hg conc significant correlation | Sweden | Skerfving et al. 1970 [ |
| Ly/CA | Hg levels in BC | dietary contaminantes fish | 23/16 | CA-Hg conc significant correlation | Sweden | Skerfving et al. 1974 [ | |
| PB/SCE, CA | Hg hair and PB levels | dietary contaminantes fish | 16/14 | No significant correlation of Hg hair levels and structural CA or SCE | Colombia | Monsalve and Chiappe 1987 [ | |
| PB Ly/cytogenetic damage | Hg hair levels | Tapajós River | 98 adults | CH3Hg contamination correlates with cytogenetic damage | Brazil | Amorim et al. 2000 [ | |
| iHg | Buccal cells/MN | Hg urine levels | artisanal and small-scale mining | 83 workers | 18.1% of exposed people had elevated MN levels | Perú | Rosales-Rimanche et al. 2013 [ |
| mHg, amalgams | WB Ly/CA | Hg blood and urine levels | Hg intoxication (10) and accidental exposure (18) | 28/7 | Significant blood and urine Hg correlation; and both with total amount of cells with CA | Belgium | Verschaeve et al. 1976 [ |
| CH3COOHgC6H5 | Ly/CA | Hg blood levels | PMA exposure | 16/12 | significant increase in hyperploidy | Belgium | Verschaeve et al. 1978 [ |
| PB/SCE | Diapers interruption lapse: 9, >9 months | diapers | 38 | Significant increase ( | Argentina | Mudry de Pargament et al. 1987 [ | |
| mHg | L/CA | Hg urine levels | chloralkali plant | 28/20 | No significant correlation | Belgium | Verschaeve et al. 1979 [ |
| PB Ly/CA | Hg blood and urine levels | hg-Zn amalgamation and chloralkali plants | 22/25 | No increase in structural CA | Belgium | Mabille et al. 1984 [ | |
| PB Ly/SCE, SCGE | Hg blood and urine levels | chlorine production department | 25/50 | Not significant difference between workers and controls | Poland | Cebulska-Wasilewska et al. 2005 [ | |
| WB/SCGE | Hg blood levels | gold mining | 61/51 | Significant Hg and damage association | Colombia | Calao and Marrugo 2015 [ | |
| mHg, oHg | WB/CA | Hg urine levels | chemical plant | 22/10 | CA was significantly higher | Switzerland | Popescu et al. 1979 [ |
| oHg | WB/SCE | Hg blood levels | seal diet | 147 | Significant Hg and SCE correlation | Greenland | Wulf et al. 1986 [ |
| elemental Hg, iHg | Blood/SCE | Hg blood levels | caustic soda, copper sheets plants | 29/26 | Significant Hg and SCE correlation | United States | Mottironi et al. 1986 [ |
| Hg vapor | PB/CBMN | Hg urine, plasma, erythrocytes levels | chloralkali plant | 26/26 | No correlation between current Hg level and MN | Sweden | Barregård et al. 1991 [ |
| WB/CA and MN | Hg blood and urine levels | chloralkali plant | 29/29 | No significant differences in CA and MN frequencies. | Norway | Hansteen et al. 1993 [ | |
| Ly/MN, SCE and HGPRT | HG urine level | chloralkali industry | 30/30 | Higher levels of MN, SCE, and HGPRT mutations | Egypt | Shamy et al. 1995 [ | |
| WB Ly/MN | Hg urine levels | mercury producing plant | 15/15 | Significant increase of MN frequency | Brazil | Queiroz et al. 1999 [ | |
| Ly/CA | Hg levels in the air | stomatological cabinets | 40/24 | Significan increase with 7 or more years of exposure | Lithuania | Lazutka et al. 1999 [ | |
| battery plant | 114/26 | ||||||
| WB/MN and SCE | Hg blood levels | river silt | 100/100 | No significant differences in MN and SCE frequencies. | Germany | Wegner et al. 2004 [ | |
| Hg fulminate | WB/CBMN, CA | Hg urine levels | explosives factory | 29/29 | Significant increase, no correlation with exposure duration nor Hg urine level | Egypt | Anwar y Gabal 1991 [ |
| iHg | WB/MN, CA, SCE | - | mercury mining | 10/10 | Significant increase | Slovenia | Al-Sabti et al. 1992 [ |
| oHg | PB Ly/MN | Hg blood levels | contaminated seafood | 51 fishermen | Significant correlation of MN frequency and total Hg in blood | Italy | Franchi et al. 1994 [ |
| iHg | uroepithelial cells/MN, NA | Hg urine levels | mining zone | 104 females | Possible association between | Mexico | Soto-Ríos et al. 2010 [ |
| blood/CBMN | Hg blood levels | environment | 110 newborns | Elevated blood Hg levels in fathers were associated with significantly higher MN | Madrid, Spain | Lope et al. 2010 [ | |
| blood/SCGE | Hg blood levels | mining sites | 50/50 | Statistical significant increase | Colombia | Cruz-Esquivel et al. 2019 [ | |
| oral mucosa cells/MN, NA | |||||||
| amalgam | Ly/CA | - | dentistry | 10 /10 | Statistical significant increase | Belgium | Verschaeve and Susanne 1979 [ |
| Ly/SCGE | - | dental restaurative fillings | 44/24 | Association between dental fillings and DNA damage | Italy | Di Pietro et al. 2008 [ | |
| Buccal cells/ | - | dental restaurative fillings | 63 | Association between dental fillings and DNA damage | Italy | Visalli et al. 2013 [ | |
| WB/SCGE | Hg urine levels | gold mining and burners | 32/32 | Greater genetic damage in those exposed than in controls | Colombia | Castaño Arias et al. 2014 [ | |
| Buccal cells/MN | - | dental restaurative fillings | 110 | Increase of genotoxic effect with dental fillings | India | Mary et al. 2018 [ |
Ly—human lymphocytes; CA—chromosomal aberrations; MN—micronuclei; WB—whole blood; C6H5Hg—phenylmercury; C2H5Hg+—ethylmercury; L—human leukocytes; PB—peripheral blood; CBMN—cytokinesis blocked micronucleus assay including not only MN but other biomarkers; SCE—sisters chromatid exchange; 8-OHdG—8-Hydroxy-2’-deoxyguanosine; (CH3)2Hg—dimethylmercury; iHg—inorganic mercury; mHg—metallic mercury; oHg—organic mercury; CH3COOHgC6H5—phenylmercury acetate; Contam water—contaminated water; SCGE—single cell gel electrophoresis or alkaline comet assay; ROS—reactive oxygen species; MI- mitotic index; BC—blood cells RBC-red BC; conc-concentration; E—exposed; C—control.